Home › Free Stock Grades › ENOV
Enovis Corporation (ENOV) Stock Grade
ENOV · Healthcare
B-
Market Cap
$1.5B
P/E Ratio
—
Revenue Growth (YoY)
+6.7%
Net Margin
-52.7%
Return on Equity
—
Dividend Yield
None
About Enovis Corporation's fundamentals
Enovis Corporation is a $1.5 billion medical devices company that generated 6.7% year-over-year revenue growth in its latest period. However, the company reported a net loss with a negative net margin of -52.7%, reflecting current unprofitability despite positive top-line expansion. Notably, the company generated positive free cash flow despite its accounting losses, suggesting operational cash generation independent of reported earnings. The company does not pay a dividend.